Clinical Trial Update: tDCS to Decrease Opioid Relapse (UG3) [NA]

View source ↗

Summary

The UG3 trial evaluating transcranial direct current stimulation (tDCS) to reduce opioid relapse has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• tDCS device

Snippet

Sponsor: Butler Hospital | Conditions: Opioid Dependence, Craving | NA | Status: COMPLETED | Results posted: 2024-09-19